Access and Reimbursement Manager (Neph Overlay - West)
Mallinckrodt Pharmaceuticals
Summary
The primary responsibility of the ARM is to help create and maintain treatment access for patients through the duration of the course of therapy. While the sales specialist drives new business demand, the ARM leads the “pull-through” process on open cases by taking compliant actions that improve access and expedite a patient's start to treatment. The ARM facilitates this process by working directly with prescribing offices, contracted Specialty Pharmacies, the Patient Service Center, and sales colleagues.
Job description
In addition to leading case “pull-through”, the ARM also identifies payer trends, alerts business partners, and takes initiative around developing, coordinating and executing tactical plans in order to create and maintain treatment access for patients. Due to the ARM’s leadership and access expertise, this individual is viewed by colleagues and customers as a valuable resource that plays a critical role in their success.
The ARM consistently demonstrates uncompromised ethics and integrity while helping others understand legal and regulatory parameters related to anti-kickback statutes, fraud and abuse, off-label promotion, and OIG guidance related to patient assistance programs.
The ideal candidate enjoys working in a fast-paced environment and has the ability to prioritize business needs, solve complex problems, develop strong customer relationships, and motivate others to take appropriate action to move cases forward. The ARM needs to quickly and successfully adapt to evolving and changing business needs.
Requirements
- Minimum of 5 years’ experience working with specialty pharmaceutical products, or minimum of 2 years’ access-related position outside of pharma
- Experience preferred in one or more of the following areas: Ophthalmology, Nephrology, Rheumatology, Pulmonology, Neurology, Dermatology
- Strong understanding of insurance and benefit design with both commercial and government payers
- Background in Access & Reimbursement, Payer account management, Specialty Pharmacy distribution, Patient Services, Case Management
- Successful navigation of complex authorization processes for specialty medications
- Working with a Patient Service Center/Hub in order to design case-specific strategies based on payer mix, benefit design, and authorization requirements
- Coordinating case pull-through with the Patient Service Center, Case Managers, Sales, and Specialty Pharmacies
- Field responsibilities that include supporting and educating HCP offices on best practices that streamline the authorization process and expedite treatment access for patients
- Communicating with SPs to improve processing time and help facilitate shipment scheduling
- Demonstrated analytical, problem solving, and relationship-building skills
- Excellent communication, organizational and leadership skills
- Customer interaction and field travel up to 60% - overnights dependent on geography
- Bachelor’s or higher degree required
Benefits
- Competitive pay
- Total Rewards benefits
- Bonus eligible
Company overview
Mallinckrodt Pharmaceuticals is a global specialty pharmaceutical company founded in 1867 with headquarters in Dublin, Ireland, and operational headquarters in the United States. The company develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies across two main segments: Specialty Brands and Specialty Generics. The Specialty Brands segment focuses on autoimmune and rare diseases in areas such as neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology, as well as immunotherapy, neonatal respiratory critical care therapies, analgesics, and gastrointestinal products. The Specialty Generics segment includes specialty generic drugs and active pharmaceutical ingredients. Mallinckrodt is particularly known for its flagship product Acthar Gel, a naturally sourced complex mixture of adrenocorticotropic hormone analogs used to treat various autoimmune disorders and medical conditions known to cause inflammation. The company has approximately 1,001-5,000 employees worldwide and operates with a direct sales presence in roughly 50 countries. Mallinckrodt has faced significant legal challenges related to opioid litigation and pricing controversies surrounding Acthar Gel, leading to bankruptcy filings in 2020 and 2023. In 2025, the company announced a merger with Endo to create a larger, diversified pharmaceuticals leader.